IRIS Accounts Production v25.1.4.42 05794330 Board of Directors 1.10.23 30.9.24 30.9.24 Medium entities the provision of care services within the welfare sector. true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh057943302023-09-30057943302024-09-30057943302023-10-012024-09-30057943302022-09-30057943302022-10-012023-09-30057943302023-09-3005794330ns15:EnglandWales2023-10-012024-09-3005794330ns14:PoundSterling2023-10-012024-09-3005794330ns10:Director12023-10-012024-09-3005794330ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3005794330ns10:MediumEntities2023-10-012024-09-3005794330ns10:Audited2023-10-012024-09-3005794330ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-10-012024-09-3005794330ns10:Medium-sizedCompaniesRegimeForAccounts2023-10-012024-09-3005794330ns10:FullAccounts2023-10-012024-09-3005794330ns10:OrdinaryShareClass12023-10-012024-09-3005794330ns10:OrdinaryShareClass22023-10-012024-09-3005794330ns10:OrdinaryShareClass32023-10-012024-09-3005794330ns10:Director22023-10-012024-09-3005794330ns10:Director32023-10-012024-09-3005794330ns10:CompanySecretary12023-10-012024-09-3005794330ns10:RegisteredOffice2023-10-012024-09-3005794330ns5:CurrentFinancialInstruments2024-09-3005794330ns5:CurrentFinancialInstruments2023-09-3005794330ns5:ShareCapital2024-09-3005794330ns5:ShareCapital2023-09-3005794330ns5:RetainedEarningsAccumulatedLosses2024-09-3005794330ns5:RetainedEarningsAccumulatedLosses2023-09-3005794330ns5:ShareCapital2022-09-3005794330ns5:RetainedEarningsAccumulatedLosses2022-09-3005794330ns5:RetainedEarningsAccumulatedLosses2022-10-012023-09-3005794330ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-3005794330ns5:LandBuildingsns5:OwnedOrFreeholdAssets2023-10-012024-09-3005794330ns5:PlantMachinery2023-10-012024-09-3005794330ns5:FurnitureFittings2023-10-012024-09-3005794330ns5:MotorVehicles2023-10-012024-09-3005794330ns5:OwnedAssets2023-10-012024-09-3005794330ns5:OwnedAssets2022-10-012023-09-3005794330ns10:OrdinaryShareClass12022-10-012023-09-3005794330ns5:LandBuildings2023-09-3005794330ns5:PlantMachinery2023-09-3005794330ns5:FurnitureFittings2023-09-3005794330ns5:MotorVehicles2023-09-3005794330ns5:LandBuildings2023-10-012024-09-3005794330ns5:LandBuildings2024-09-3005794330ns5:PlantMachinery2024-09-3005794330ns5:FurnitureFittings2024-09-3005794330ns5:MotorVehicles2024-09-3005794330ns5:LandBuildings2023-09-3005794330ns5:PlantMachinery2023-09-3005794330ns5:FurnitureFittings2023-09-3005794330ns5:MotorVehicles2023-09-3005794330ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3005794330ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3005794330ns5:WithinOneYear2024-09-3005794330ns5:WithinOneYear2023-09-3005794330ns5:BetweenOneFiveYears2024-09-3005794330ns5:BetweenOneFiveYears2023-09-3005794330ns5:AllPeriods2024-09-3005794330ns5:AllPeriods2023-09-3005794330ns5:DeferredTaxation2023-09-3005794330ns5:OtherProvisionsContingentLiabilities2023-09-3005794330ns5:DeferredTaxation2023-10-012024-09-3005794330ns5:OtherProvisionsContingentLiabilities2023-10-012024-09-3005794330ns5:DeferredTaxation2024-09-3005794330ns5:OtherProvisionsContingentLiabilities2024-09-3005794330ns10:OrdinaryShareClass12024-09-3005794330ns10:OrdinaryShareClass22024-09-3005794330ns10:OrdinaryShareClass32024-09-3005794330ns5:RetainedEarningsAccumulatedLosses2023-09-30
REGISTERED NUMBER: 05794330 (England and Wales)
















THE SUPERIOR HEALTHCARE GROUP LTD

STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024






THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Income Statement 9

Other Comprehensive Income 10

Statement of Financial Position 11

Statement of Changes in Equity 12

Statement of Cash Flows 13

Notes to the Statement of Cash Flows 14

Notes to the Financial Statements 15


THE SUPERIOR HEALTHCARE GROUP LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: S Thorp
C Thorp
S Richards





SECRETARY: S Thorp





REGISTERED OFFICE: Gazette House
5-8 Estuary View Business Park
Boorman Way
Whitstable
Kent
CT5 3SE





REGISTERED NUMBER: 05794330 (England and Wales)





INDEPENDENT AUDITORS: Lakeview Southern Audit Limited
Chartered Accountants and
Statutory Auditors
2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their strategic report for the year ended 30 September 2024.

FAIR REVIEW OF BUSINESS
The principal activity of The Superior Healthcare Group Ltd continued to be the provision of specialist, nurse-led care that supports children and adults who have complex, long term health conditions to live safely at home.

Building upon the continued investments made in both our team and resources in previous financial years, the business grew the average number of complex care hours that it delivered to nearly 10,000 hours per week by 30th September 2024.

The directors consider the performance of the Company to be satisfactory and believe that our business is well placed to grow again in the forthcoming year.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors have identified that the business is exposed to the following risks:

Loss of registration
The Superior Healthcare Group Ltd's services are regulated by the Care Quality Commission and failure to comply with the CQC regulations could impact the Company's ability to provide our services. The directors seek to maintain compliance with the regulations through ongoing monitoring and internal assessment of compliance with statutory regulations. The current rating awarded to The Superior Healthcare Group Ltd by the Care Quality Commission is Good.

Loss of contract
The Company works extensively with NHS ICBs which continue to combine to create a smaller number of commissioning organisations. The directors seek to mitigate exposure to any single ICB through expansion of our geographic footprint and continued diversification of our client base.

Recruitment and employee retention
The Company's ability to deliver and grow its services depends upon the continued growth of our skilled team of carers and nurses. The Company invests heavily to both retain valued members of our team and to attract new employees to our businesses - not least by offering competitive rates of pay, prompt, regular and accurate payment of wages and an increasing range of employee benefits and wellbeing initiatives. The Superior Healthcare Group Ltd employs an in house team of trainers and clinical educators and offers funded diplomas and additional training opportunities to support employees to progress their careers.

Financial risk management
Credit risk - the principal credit risk arises from the Company's trade debtors. In order to manage credit risk, the Company reviews payment history, third party credit references, debt ageing and collection history on a regular basis.
Interest rate risk - the directors do not consider that the Company is materially exposed to the risk of interest rate rises.
Liquidity risk - the Company ensures that it has sufficient cash to meet the needs of the business through weekly cash forecasting and has effective, long-standing arrangements to support the working capital requirements of the business.

IT systems
The Company's operations depend upon a number of cloud-based IT systems. The directors ensure the security of our systems and data through the procurement of dedicated support contracts.


THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

KEY PERFORMANCE INDICATORS
The directors use a range of financial and non-financial key performance indicators to monitor the performance of the business and, in particular, monitors the following KPIs:

2024 2023 Change
Average number of care hours fulfilled weekly: 9,863 8,226 + 20%
Average weekly sales: £379,672 £291,122 + 30%
Average number of carers and nurses paid weekly: 330 271 + 22%
Average weekly working hours per carer and nurse: 30 31 - 3%

FUTURE DEVELOPMENTS
Since 30th September 2024, the Company continues to experience significant demand for our services. Our ability to fulfil the demands of our existing and prospective clients depends upon our ability to attract new people to the Company and to ensure a high rate of retention and engagement amongst our existing team. These continue to be our priorities for the year ahead.

The directors aim to continue to grow our businesses at a sustainable rate which ensures the quality of service that the people that we support rightly expect and to promote an environment in which our employees have the opportunity to thrive.

ON BEHALF OF THE BOARD:





S Thorp - Director


17 June 2025

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


The directors present their report with the financial statements of the company for the year ended 30 September 2024.

DIVIDENDS
The total distribution of dividends paid to The Superior Healthcare Group Ltd's parent for the year ended 30th September 2024 will be £1,650,000 (2023 - £500,000).

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2023 to the date of this report.

S Thorp
C Thorp
S Richards

EMPLOYEE ENGAGEMENT STATEMENT
Employee engagement is key to the Company's ability to attract and retain our employees and to the Company's overall success. The Company goes to significant lengths to provide a great working experience for colleagues including by providing an open and transparent working environment in which news and developments are shared. The Company provides structured as well as ad-hoc supervision sessions for employees and opportunities for our employees to develop their career prospects through providing access to ongoing training including apprenticeships. The Company has achieved significant successes through the promotion of longstanding employees; all career opportunities are advertised internally and promotions are celebrated by the business.

The Company employs a dedicated wellbeing team and provides all employees access to an employee assistance programme which includes providing access to counselling sessions where events in our employees' lives including homelives lead them to require extra support.

We fundamentally understand that our clients' wellbeing and the Company's success depends upon our people - and recognise our employees as our most valuable asset. To that end, the Company and directors are committed to finding opportunities to continually improve our employees' experience of working for us - and continue to evaluate our success in this area through regular employee surveys, supervision sessions and by providing other opportunities for employees to offer feedback and suggestions.

DISABLED PERSONS
Applications for employment by disabled persons will always be fully and proactively considered. In the event that employees become disabled, every effort is made to ensure that their employment within the Company continues and that appropriate support is offered and adjustments, made. It is the Company's policy that the training, career development and promotion of disabled people should, as far as possible, be identical to that of other employees.

MATTERS COVERED IN THE STRATEGIC REPORT
Information in respect of the business review, future developments, post balance sheet events, financial risk management and exposure to risks are not shown in the Directors' Report because they are presented in the Strategic Report in accordance with s414c(ii) of the Companies Act 2006.


THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

DIRECTORS' RESPONSIBILITIES STATEMENT
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, Lakeview Southern Audit Limited, are deemed to be reappointed in accordance with the Companies Act 2006 s.487 (2).

ON BEHALF OF THE BOARD:





S Thorp - Director


17 June 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE SUPERIOR HEALTHCARE GROUP LTD


Opinion
We have audited the financial statements of The Superior Healthcare Group Ltd (the 'company') for the year ended 30 September 2024 which comprise the Income Statement, Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, Statement of Cash Flows and Notes to the Statement of Cash Flows, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 September 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE SUPERIOR HEALTHCARE GROUP LTD


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Directors' Responsibilities Statement set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We considered the central laws and regulations to the entity and identified those being of significance. We undertook an enquiry of management and those charged with governance to evaluate those of significance and any instances of non-compliance.

Through discussion and, where appropriate, written representation we obtained an understanding of the entity's policies and procedures in relation to fraud risks, including knowledge of any actual, suspected or alleged fraud.

The Senior Statutory Auditor has assessed that the engagement team collectively have the appropriate competence and capabilities to identify or recognise non-compliance with laws and regulations within the areas that they are responsible for testing.

Where necessary, documentation scrutiny was used to determine the significance of any instances with non-compliance of central laws and regulations and reviewed disclosures made in the financial statements to ensure these were appropriately made. We also reviewed the journals processed by the finance team and reviewed all transactions outside the normal course of the entity's business.

We communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

Irregularities that result from fraud are inherently more difficult to detect from irregularities that result from error.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
THE SUPERIOR HEALTHCARE GROUP LTD


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Adrian Hull (Senior Statutory Auditor)
for and on behalf of Lakeview Southern Audit Limited
Chartered Accountants and
Statutory Auditors
2 Lakeview Stables
Lower St. Clere
Kemsing
Sevenoaks
Kent
TN15 6NL

17 June 2025

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

INCOME STATEMENT
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   

TURNOVER 19,850,216 15,179,951

Cost of sales 11,812,214 9,187,953
GROSS PROFIT 8,038,002 5,991,998

Administrative expenses 5,816,404 5,068,374
OPERATING PROFIT 4 2,221,598 923,624

Interest receivable and similar income 147 -
2,221,745 923,624

Interest payable and similar expenses 5 - 2,314
PROFIT BEFORE TAXATION 2,221,745 921,310

Tax on profit 6 539,806 223,611
PROFIT FOR THE FINANCIAL YEAR 1,681,939 697,699

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   

PROFIT FOR THE YEAR 1,681,939 697,699


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

1,681,939

697,699

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 8 399,321 559,022

CURRENT ASSETS
Debtors 9 2,047,467 2,280,853
Cash at bank 481,000 77,936
2,528,467 2,358,789
CREDITORS
Amounts falling due within one year 10 2,241,183 2,230,466
NET CURRENT ASSETS 287,284 128,323
TOTAL ASSETS LESS CURRENT
LIABILITIES

686,605

687,345

PROVISIONS FOR LIABILITIES 14 70,873 103,552
NET ASSETS 615,732 583,793

CAPITAL AND RESERVES
Called up share capital 15 1,209 1,209
Retained earnings 16 614,523 582,584
SHAREHOLDERS' FUNDS 615,732 583,793

The financial statements were approved by the Board of Directors and authorised for issue on 17 June 2025 and were signed on its behalf by:





S Thorp - Director


THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 SEPTEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 October 2022 1,209 384,885 386,094

Changes in equity
Dividends - (500,000 ) (500,000 )
Total comprehensive income - 697,699 697,699
Balance at 30 September 2023 1,209 582,584 583,793

Changes in equity
Dividends - (1,650,000 ) (1,650,000 )
Total comprehensive income - 1,681,939 1,681,939
Balance at 30 September 2024 1,209 614,523 615,732

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 2,404,578 (33,134 )
Interest paid - (2,314 )
Tax paid (186,226 ) (46,230 )
Net cash from operating activities 2,218,352 (81,678 )

Cash flows from investing activities
Purchase of tangible fixed assets (30,114 ) (315,506 )
Sale of tangible fixed assets 8,810 1,160
Interest received 147 -
Net cash from investing activities (21,157 ) (314,346 )

Cash flows from financing activities
Intercompany loan movements (144,131 ) 137,607
Equity dividends paid (1,650,000 ) (500,000 )
Net cash from financing activities (1,794,131 ) (362,393 )

Increase/(decrease) in cash and cash equivalents 403,064 (758,417 )
Cash and cash equivalents at beginning of
year

2

77,936

836,353

Cash and cash equivalents at end of year 2 481,000 77,936

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

30.9.24 30.9.23
£    £   
Profit before taxation 2,221,745 921,310
Depreciation charges 184,082 189,782
Profit on disposal of fixed assets (3,076 ) (1,160 )
Finance costs - 2,314
Finance income (147 ) -
2,402,604 1,112,246
Decrease/(increase) in trade and other debtors 64,273 (888,511 )
Decrease in trade and other creditors (62,299 ) (256,869 )
Cash generated from operations 2,404,578 (33,134 )

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect of these Statement of Financial Position amounts:

Year ended 30 September 2024
30.9.24 1.10.23
£    £   
Cash and cash equivalents 481,000 77,936
Year ended 30 September 2023
30.9.23 1.10.22
£    £   
Cash and cash equivalents 77,936 836,353


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.10.23 Cash flow At 30.9.24
£    £    £   
Net cash
Cash at bank 77,936 403,064 481,000
77,936 403,064 481,000
Total 77,936 403,064 481,000

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

The Superior Healthcare Group Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

All income is recorded in the period in which the care is physically carried out.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Leasehold improvements - 10% on cost
Office equipment - 20% on cost
Computer equipment - 33% on cost
Motor vehicles - 25% on reducing balance

Tangible fixed assets are stated at cost less accumulated depreciation.

Assets held under finance leases are depreciated in the same way as owned assets.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classified as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains and losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts are capitalised as tangible fixed assets. These are depreciated over their useful lives. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.

Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account on a straight line basis.

3. EMPLOYEES AND DIRECTORS
30.9.24 30.9.23
£    £   
Wages and salaries 12,332,253 10,212,876
Social security costs 1,195,593 991,788
Other pension costs 202,801 170,077
13,730,647 11,374,741

The average number of employees during the year was as follows:
30.9.24 30.9.23

Direct 331 271
Admin 32 68
Group employees working for this company 37 3
400 342

30.9.24 30.9.23
£    £   
Directors' remuneration - 5,000

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes - 1

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


4. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

30.9.24 30.9.23
£    £   
Depreciation - owned assets 184,081 189,783
Profit on disposal of fixed assets (3,076 ) (1,160 )
Auditors' remuneration 15,380 15,380
Auditors' remuneration for non audit work 12,759 16,361

5. INTEREST PAYABLE AND SIMILAR EXPENSES
30.9.24 30.9.23
£    £   
Loan - 2,314

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
30.9.24 30.9.23
£    £   
Current tax:
UK corporation tax 572,486 186,227

Deferred tax (32,680 ) 37,384
Tax on profit 539,806 223,611

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

30.9.24 30.9.23
£    £   
Profit before tax 2,221,745 921,310
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2023 - 25%)

555,436

230,328

Effects of:
Expenses not deductible for tax purposes 7,084 6,967
Capital allowances in excess of depreciation and net of deferred tax movement
2,769

18,767
Group relief (25,483 ) (7,136 )

Effect of changes in corporation tax rates - (25,315 )
Total tax charge 539,806 223,611

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


7. DIVIDENDS
30.9.24 30.9.23
£    £   
Ordinary A shares of £1 each
Interim 1,650,000 500,000

8. TANGIBLE FIXED ASSETS
Leasehold Office Computer Motor
improvements equipment equipment vehicles Totals
£    £    £    £    £   
COST
At 1 October 2023 294,470 682,511 286,311 85,472 1,348,764
Additions 7,048 5,111 17,955 - 30,114
Disposals - - - (11,897 ) (11,897 )
At 30 September 2024 301,518 687,622 304,266 73,575 1,366,981
DEPRECIATION
At 1 October 2023 134,020 371,352 223,535 60,835 789,742
Charge for year 27,083 119,187 32,471 5,340 184,081
Eliminated on disposal - - - (6,163 ) (6,163 )
At 30 September 2024 161,103 490,539 256,006 60,012 967,660
NET BOOK VALUE
At 30 September 2024 140,415 197,083 48,260 13,563 399,321
At 30 September 2023 160,450 311,159 62,776 24,637 559,022

9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 1,272,304 1,558,999
Amounts owed by group undertakings - 169,113
Amounts recoverable on contract 483,549 319,175
Prepayments 291,614 233,566
2,047,467 2,280,853

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade creditors 214,247 172,803
Amounts owed to group undertakings 450,206 763,450
Tax 572,487 186,227
Social security and other taxes 265,522 273,626
Other creditors 624,643 769,089
Accruals and deferred income 114,078 65,271
2,241,183 2,230,466

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


11. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.9.24 30.9.23
£    £   
Within one year 230,662 221,389
Between one and five years 529,150 213,973
759,812 435,362

12. SECURED DEBTS

The following secured debts are included within creditors:

30.9.24 30.9.23
£    £   
Invoice discounting facility - 263,592

The invoice discounting facility is secured by a debenture over the assets of the company. The debenture contains both fixed and floating charges. The floating charge covers all the property or undertaking of the company.

13. FINANCIAL INSTRUMENTS

The company has basic financial debt instruments which are all measured at cost. These include trade debtors, other debtors, cash at bank, trade creditors and other creditors.

14. PROVISIONS FOR LIABILITIES
30.9.24 30.9.23
£    £   
Deferred tax 70,873 103,552

Deferred Other
tax provisions
£    £   
Balance at 1 October 2023 103,552 84,073
Provided during year (32,679 ) -
Balance at 30 September 2024 70,873 84,073

15. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
1,200 Ordinary A £1 1,200 1,200
1 Ordinary B £1 1 1
8 Ordinary C £1 8 8
1,209 1,209

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


15. CALLED UP SHARE CAPITAL - continued

The ordinary A shares have voting rights, an entitlement to dividends and an entitlement to distribution on liquidation or sale.

The ordinary B shares hold no voting rights, have an entitlement to dividends, and will have no rights over surplus assets or proceeds should the company be liquidated or sold.

The ordinary C shares hold no voting rights, have an entitlement to dividends, and will have no rights over surplus assets or proceeds should the company be liquidated or sold.

16. RESERVES
Retained
earnings
£   

At 1 October 2023 582,584
Profit for the year 1,681,939
Dividends (1,650,000 )
At 30 September 2024 614,523

The retained earnings is the cumulative profit and loss net of distributions.

17. PENSION COMMITMENTS

The company makes contributions to a defined contribution pension scheme. During the year contributions of £202,801 (2023: £170,224) were paid. The contributions due are those specified under the legal requirements of Auto-enrolment. The cost of these contributions are charged to the statement of comprehensive income on an accruals basis as they become payable under the scheme.

18. RELATED PARTY DISCLOSURES

The company owed £103 (2023: £286,074) to its parent company The Superior Healthcare Group Holdings Ltd, £103 (2023: £477,376) to Superior Payroll Ltd, a fellow company within the group and £450,000 (2023: £Nil) to the ultimate parent company, Healthcare Investment Group Limited at 30 September 2024.

The company was owed £Nil (2023: £12,113) by HRS Healthcare Ltd and £Nil (2023: £157,000) by Superior Nursing Services Ltd, both fellow companies within the group at 30 September 2024.

During the year, services of £473 (2023: £2,979) were supplied to the fellow group company Superior Nursing Services Ltd and services of £62,022 (2023: £66,866) were received and services of £89,816 (2023: £Nil) were received by the fellow group company HRS Healthcare Ltd.

During the year wages totalling £1,516,693 (2023: £736,312) and £42,315 (2023: £Nil) were processed and paid by fellow group companies Superior Payroll Ltd and HRS Healthcare Ltd respectively relating to The Superior Healthcare Group Ltd.

19. ULTIMATE CONTROLLING PARTY

The ultimate controlling parties are S Thorp and C Thorp.

THE SUPERIOR HEALTHCARE GROUP LTD (REGISTERED NUMBER: 05794330)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


20. ULTIMATE PARENT COMPANY

Healthcare Investment Group Limited is regarded by the directors as being the company's ultimate parent company.

The Superior Healthcare Group Holdings Ltd holds the entire issued share capital of The Superior Healthcare Group Ltd.

The registered office where the financial statements may be obtained is Gazette House 5-8 Estuary View Business Park, Boorman Way, Whitstable, Kent, CT5 3SE.